Specialty Pharma ApS: Financial statements 2024
CVR: 38476599
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Specialty Pharma ApS (CVR 38476599) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 96,397 and a net result of DKK -53,758 compared with DKK 80,692 the year before. That is a decrease of 67.1% compared with the year before. Equity in the 2024 report amounted to DKK 40,750. The solvency ratio was 25.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 96,397
- Profit/Loss
- DKK -53,758
- Equity
- DKK 40,750
- Total Assets
- DKK 157,690
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 96 t. | -54 t. | 41 t. | 1 |
| 2023 | - | 293 t. | 81 t. | 95 t. | 1 |
| 2022 | - | 1 mio. | 41 t. | 14 t. | 1 |
| 2021 | - | 639 t. | -44 t. | -27 t. | 2 |
| 2020 | - | 944 t. | -39 t. | 17 t. | 2 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Specialty Pharma ApS has published its annual report for 2023. Gross profit came to DKK 292,693, and the net result was DKK 80,692.
About Specialty Pharma ApS
Specialty Pharma ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2017. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Ulla Haaning Singapuri. The company is owned by Ulla Haaning Singapuri. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 216,735 and a net result of DKK -58,566 compared with DKK -53,758 the year before. Equity in the 2025 report amounted to DKK -17,816.